The oldest ancient dog genomes on record all come from a population that lived alongside Ice Age hunter-gatherers across ...

The Justice Department has installed a Missouri-based U.S. prosecutor to head the Trump administration’s election probe in Fulton County, Georgia, according to recent court records, marking the latest ...

Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon Therapeutics in 2023, hit the primary endpoint in a phase 2 trial for discoid lupus ...

Usama has a passion for video games and a talent for capturing their magic in writing. He brings games to life with his words, and he's been fascinated by games for as long as he's had a joystick in ...

Graham Taylor has previously received funding from Cancer Research UK, Blood Cancer UK, the UK Medical Research Council, Melanoma UK, and the University of Birmingham to support his research team.

Lupus overwhelmingly affects women – we still don't know why – and while many people keep lupus in check through medication, about 5% of sufferers experience life-threatening complications. The ...

Kathleen Ford of Solano County was a nurse for more than 20 years, until one day she squatted down to help a patient and, hobbled by terrible joint pain, couldn’t stand up. Then in her 60s, Ford had ...

For years scientists have suspected that the Epstein-Barr virus (EBV)—a type of herpesvirus that infects 94 percent of the global population by adulthood and causes mononucleosis (aka “mono”)—might be ...

The virus behind glandular fever, also known as mononucleosis or kissing disease, seems to infect and reprogram immune cells in the body, priming some people to develop the autoimmune condition lupus.

A newly discovered molecule may hold the key to rebalancing the immune system in lupus and autoimmune diseases. A newly discovered molecule may hold the key to rebalancing the immune system in lupus ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved obinutuzumab for the treatment of adults with active lupus nephritis who are receiving ...